Healthcare-focused private equity firm BelHealth Investment Partners has hired Marc Aronstein as a managing director. Previously, Aronstein worked at The Marwood Group where he recently served as a managing director and co-head of private equity investing and M&A.
New York, NY – February 26, 2015 – BelHealth Investment Partners, a healthcare-focused private equity firm, announced that Marc Aronstein has joined the Company as a Managing Director who will be responsible for originating, structuring and executing Fund transactions.
Mr. Aronstein has twenty-three years of investing experience, including seventeen years of direct private equity experience. He recently served as a Managing Director and Co-Head of Private Equity Investing and Mergers and Acquisitions at The Marwood Group, where he led transactions and worked extensively with lower middle market healthcare services companies. Previously, Mr. Aronstein was a Managing Director at The Beekman Group, a private equity firm focused on investing in lower middle market companies, where he assumed lead roles in sourcing and executing investments and initiated a focused healthcare investing effort, concentrating in thirty healthcare sub-sectors. Mr. Aronstein was previously a Partner of Odeon Capital Partners, a private equity fund and where he served as a director of five companies. He began his private equity investing career at EXOR America and Morgan Lewis Githens & Ahn, where he focused on making control investments in middle market companies. Mr. Aronstein also served as the Chief Financial Officer of The River Group, a consumer products company and as an investment banker at Merrill Lynch & Co. in their Merchant Banking and High Yield Finance groups.
Mr. Aronstein earned an M.B.A from Harvard Business School and a Bachelor of Science in Economics with a concentration in Finance with honors from the Wharton School of the University of Pennsylvania. Dennis Drislane, BelHealth Managing Partner said, “We are thrilled to welcome Marc to our Fund. He is an experienced and successful healthcare investor and we look forward to his perspective as a key member of our investment team. As we grow, we are focused on adding talented and experienced individuals with a passion for healthcare investing. Marc has a long investment history, deep healthcare insight and experience and a track record of executing transactions in the lower middle market.”
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies that would benefit from BelHealth’s vast operating and private equity experience. The firm typically invests $15-40 million per platform company across four healthcare segments: Services, Distribution, Products and Information Technology. Applying an active, hands-on approach, BelHealth utilizes its experience to support management, drive revenue and profit growth and achieve superior returns for its investors and partners.